References
- Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?. Arch Intern Med 2001;161:1443–7.
- Spyropoulos AC. Bridging therapy and oral anticoagulation: current and future prospects. Curr Opin Hematol 2010;17:444–9.
- Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin – fourth edition. Br J Haematol 2011;154:311–24.
- Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother 2011;45: 990–9.
- Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367:404–11.
- Toulon P, Ozier Y, Ankri A, et al. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009;101:394–401.
- Rizos T, Jenetzky E, Herweh C, et al. Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage. Neurocrit Care 2010;13:321–5.
- Rizos T, Jenetzky E, Herweh C, et al. Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage. Ann Neurol 2010;67:788–93.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1: 307–10.
- Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001;119:194S–206S.
- Verret L, Couturier J, Rozon A, et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy 2012;32:871–9.
- Bereznicki LR, Jackson SL, Peterson GM, et al. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007;60:311–4.
- Leiria TLL, Pellanda LC, Magalhães E, de Lima GG. Comparative study of a portable system for prothrombin monitoring using capillary blood against venous blood measurements in patients using oral anticoagulants: correlation and concordance. Arq Bras Cardiol 2007;89:1–5.
- Meijer P, Kluft C, Poller L, et al. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors. Am J Clin Pathol 2006;126:756–61.
- Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369–429.
- Rizos T, Horstmann S, Jenetzky E, et al. Oral anticoagulants–a frequent challenge for the emergency management of acute ischemic stroke. Cerebrovasc Dis 2012;34:411–8.
- Batchelor JS, Grayson A. A meta-analysis to determine the effect of anticoagulation on mortality in patients with blunt head trauma. Br J Neurosurg 2012;26:525–30.
- Yamashita S, Kimura K, Iguchi Y, Shibazaki K. Prior oral antithrombotic therapy is associated with early death in patients with supratentorial intracerebral hemorrhage. Intern Med 2011;50:413–9.
- Cervera A, Amaro S, Chamorro A. Oral anticoagulant-associated intracerebral hemorrhage. J Neurol 2012;259:212–24.
- Narayan RK, Maas AIR, Servadei F, et al. Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma 2008;25:629–39.
- Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of acute subdural hematomas. Neurosurgery 2006;58:S16–24; discussion Si–iv.
- Dentali F, Marchesi C, Pierfranceschi MG, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 2011;106:429–38.
- Liotta EM, Garg RK, Temes RE, et al. Warfarin-associated intracerebral hemorrhage is inadequately treated at community emergency departments. Stroke 2012;43:2503–5.
- Chong CT, Lew TWK, Kuperan P, et al. Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates. Anaesth Intensive Care 2010;38:474–80.
- Barillari G, Pasca S, Barillari A, De Angelis V. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. Blood Transfus 2012;10:87–94.
- Van Ryn J, Baruch L, Clemens A. Interpretation of point- of-care INR results in patients treated with dabigatran. Am J Med 2012;125:417–20.
- Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol 2012;110:453–60.
- Kirley K, Qato DM, Kornfield R, Stafford RS, Alexander GC. National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes 2012;5:615–21.